These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
163 related items for PubMed ID: 6469763
1. Enhancement of artificial lung metastases by misonidazole. Rockwell S, Nierenburg M, Irvin CG. Int J Radiat Oncol Biol Phys; 1984 Aug; 10(8):1395-8. PubMed ID: 6469763 [Abstract] [Full Text] [Related]
5. Combination therapy with misonidazole and mitomycin C: lack of chemosensitization of EMT6 tumor cells in vivo or in vitro. Rockwell S. Int J Radiat Oncol Biol Phys; 1984 Sep; 10(9):1631-4. PubMed ID: 6434497 [Abstract] [Full Text] [Related]
6. In vitro assessment of the oncogenic potential of nitroimidazole radiosensitizers. Hei TK, Geard CR, Osmak RS, Hall EJ. Int J Radiat Oncol Biol Phys; 1985 Sep; 11(9):1653-8. PubMed ID: 3839777 [Abstract] [Full Text] [Related]
7. Testing of new hypoxic cell sensitizers in vivo. Stone HB, Sinesi MS. Radiat Res; 1982 Jul; 91(1):186-98. PubMed ID: 6212963 [No Abstract] [Full Text] [Related]
8. Effect of 1-methyl-5-sulfonamide-4-nitroimidazole and 1-methyl-5-bromide-4-nitroimidazole on the radiosensitivity of EMT6 tumor cells. Rockwell S, Irvin CG, Nierenburg M. Cancer Treat Rep; 1986 Mar; 70(3):411-3. PubMed ID: 3955554 [Abstract] [Full Text] [Related]
9. The effect of hypoxic radiosensitizer after mild hyperthermia in C3H mammary carcinoma. Ohizumi Y, Murayama C, Maezawa H, Mori T. Tokai J Exp Clin Med; 1984 Oct; 9(4):331-7. PubMed ID: 6537042 [Abstract] [Full Text] [Related]
10. Dual function nitroimidazoles less toxic than RSU 1069: selection of candidate drugs for clinical trial (RB 6145 and/or PD 130908. Cole S, Stratford IJ, Fielden EM, Adams GE, Leopold W, Elliott W, Suto M, Sebolt-Leopold J. Int J Radiat Oncol Biol Phys; 1992 Oct; 22(3):545-8. PubMed ID: 1735694 [Abstract] [Full Text] [Related]
12. In vivo cytotoxicity of misonidazole and hyperthermia in a transplanted mouse mammary tumor. Lehman CM, Stewart JR. Radiat Res; 1983 Dec; 96(3):628-34. PubMed ID: 6657927 [Abstract] [Full Text] [Related]
16. [Radiosensitizing effect of a 2-nitroimidazole hydroxamate (KIN-804) to murine tumors]. Tada T, Nakajima T, Onoyama Y, Nagasawa H, Hori H, Inayama S. Nihon Igaku Hoshasen Gakkai Zasshi; 1992 May 25; 52(5):688-90. PubMed ID: 1508643 [Abstract] [Full Text] [Related]
17. Radiosensitization, pharmacokinetics, and toxicity of a 2-nitroimidazole nucleoside (RA-263). Agrawal KC, Rupp WD, Rockwell S. Radiat Res; 1986 Feb 25; 105(2):227-39. PubMed ID: 3754053 [Abstract] [Full Text] [Related]
18. Azomycin riboside: a new radiosensitizer. Pedersen JE, Barron G, Chapman JD. Int J Radiat Oncol Biol Phys; 1982 Feb 25; 8(3-4):415-8. PubMed ID: 7107360 [Abstract] [Full Text] [Related]
19. Modulation of prostaglandin biosynthesis in hypoxic murine mammary adenocarcinoma cells by misonidazole. Shalinsky DR, McNamara DB, Agrawal KC. Cancer Res; 1989 Jul 15; 49(14):3853-6. PubMed ID: 2736527 [Abstract] [Full Text] [Related]
20. Newly synthesized hypoxia-mediated drugs as radiosensitizers and cytotoxic agents. Astor M, Hall EJ, Biaglow JE, Parham JC. Int J Radiat Oncol Biol Phys; 1982 Jan 15; 8(1):75-83. PubMed ID: 7061257 [Abstract] [Full Text] [Related] Page: [Next] [New Search]